Basic Information
Dragonfly Sciences has developed a new class of biosimilar products for complex monoclonal antibodies and soluble receptors. Dragonfly Sciences develops and markets biosimilars for monoclonal antibodies and soluble receptors.
Dragonfly Sciences
Massachusetts,United States of America
15~50 people
January 01, 2005
--
--
Enterprise Profile
Industrial Sector
Technology
Application Scenarios